Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia

This study has been withdrawn prior to recruitment.

Study NCT00030355 Information provided by National Cancer Institute (NCI)

First Received: February 14, 2002 Last Updated: November 7, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given